CC
BMY.RT

Casdin Capital’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Casdin Capital’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,250,000
Closed -$4.31M – 56
2020
Q4 		$4.31M Hold
6,250,000
– – 0.13% 49
2020
Q3 		$14.1M Buy
6,250,000
+3,300,000
+112% +$9.42M 0.63% 33
2020
Q2 		$10.6M Buy
2,950,000
+450,000
+18% +$1.62M 0.63% 34
2020
Q1 		$9.5M Buy
2,500,000
+1,000,000
+67% +$3.29M 1.01% 30
2019
Q4 		$4.51M Buy
+1,500,000
New +$3.9M 0.42% 31

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return